Willingness of individuals with Li-Fraumeni syndrome to participate in a cancer prevention trial: a survey study

Fam Cancer. 2023 Oct;22(4):495-497. doi: 10.1007/s10689-023-00339-y. Epub 2023 Jun 23.

Authors

Farina J Struewe¹, Sarah Schott², Martina de Zwaan³, Christian P Kratz⁴

Affiliations

¹ Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany.
² Department of Gynecology and Obstetrics, University Hospital Heidelberg, Heidelberg, Germany.
³ Department of Psychosomatic Medicine and Psychotherapy, Hannover Medical School, Hannover, Germany.
⁴ Pediatric Hematology and Oncology, Hannover Medical School, Hannover, Germany. kratz.christian@mh-hannover.de.

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Genetic Predisposition to Disease
Germ-Line Mutation
Humans
Li-Fraumeni Syndrome* / genetics
Tumor Suppressor Protein p53 / genetics

Substances

Tumor Suppressor Protein p53